Washington, DC (September 15, 2020) — Today the American College of Physicians (ACP) released a new policy paper focused on increasing competition in the marketplace and addressing anticompetitive behaviors to combat the rising costs of prescription drugs. The new paper titled “Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians”, is the third installment of a series published in Annals of Internal Medicine.
Washington, DC (September 11, 2020) — Today the American College of Physicians (ACP) sent a letter to every member of Congress stressing the importance that the planned increases in payments for evaluation and management (E/M) services and other changes to the Medicare Physician Fee Schedule move forward as scheduled on Jan. 1.
Statement attributable to:
Heather E. Gantzer, MD, FACP
Chair, Board of Regents, American College of Physicians
